Brief: Dishman Carbogen Amcis’S Bavla Site Inspected By Japanese Pharmaceuticals And Medical Devices Agency (PMDA), Final Report Awaited
09/08/2023 13:27
Aug 9 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS :
* CO’S BAVLA SITE INSPECTED BY JAPANESE PHARMACEUTICALS AND
MEDICAL DEVICES AGENCY (PMDA), FINAL REPORT AWAITED
Source text for Eikon: ID:nBSE2wjrSw
Further company coverage: DSHM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis